newsfilter
← Latest News
Business Wire·

AVROBIO to Participate in Four Upcoming Investor Conferences in September

AVROBIO, Inc. (NASDAQ:AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced that members of its senior management team are scheduled to participate in four upcoming investor confe